Search Results1-20 of  43

  • 1 / 3
  • KAWAGUCHI YASURO ID: 9000255748833

    Research Institute, Taiho Pharmaceutical Co., Ltd. (1988 from CiNii)

    Articles in CiNii:1

    • PROTEIN BINDING OF CEFODIZIME (THR-221) (1988)
  • KAWAGUCHI YASURO ID: 9000255748836

    Research Institute, Taiho Pharmaceutical Co., Ltd. (1988 from CiNii)

    Articles in CiNii:1

    • DISTRIBUTION AND EXCRETION OF <SUP>14</SUP>C-CEFODIZIME SODIUM (<SUP>14</SUP>C-THR-221) IN MICE AND RATS (1988)
  • KAWAGUCHI YASURO ID: 9000255748849

    Research Institute, Taiho Pharmaceutical Co., Ltd. (1988 from CiNii)

    Articles in CiNii:1

    • PHARMACOKINETICS OF CEFODIZIME SODIUM (THR-221) IN EXPERIMENTAL ANIMALS (1988)
  • KAWAGUCHI YASURO ID: 9000256148478

    Research Laboratory, Taiho Pharmaceutical Co., Ltd. (1977 from CiNii)

    Articles in CiNii:1

    • STUDIES ON THE MECHANISM OF ACTION OF FT-207 (1977)
  • KAWAGUCHI YASURO ID: 9000256155314

    Section of Biochemistry, Research Laboratory, Taiho Pharmaceutical Co., Ltd. (1981 from CiNii)

    Articles in CiNii:1

    • Studies on combination therapy with 1-(tetrahydro-2-furanyl)-5-fluorouracil plus uracil I. Effect of coadministration of uracil on the antitumor activity of 1-(terahydro-2-furanyl)-5-fluorouracil and the level of 5-fluorouracil in AH 130 bearing rats.:Effect of Coadministration of Uracil on the Antitumor Activity of 1-(Terahydro-2-fureny1)-5-fluorouracil and the Level of 5-Fluorouracil in AH 130 bearing Rats (1981)
  • KAWAGUCHI YASURO ID: 9000392667145

    Articles in CiNii:1

    • Studies on the Fate of 1-(2-Tetrahydrofuryl)-5-fluorouracil (FT-207), a Carcinostatic Agent. III. Absorption, Distribution, Excretion and Metabolism after Rectal Administration of FT-207 (1975)
  • KAWAGUCHI YASURO ID: 9000392667631

    Articles in CiNii:1

    • Studies on the Fate of 5-Fluoro-1, 3-bis (tetrahydro-2-furanyl)-2, 4-pyrimidinedione (FD-1), a New Antitumor Agent. I. Absorption, Distribution, Excretion and Metabolism of FD-1 administered orally to Rats (1978)
  • KAWAGUCHI Yasuro ID: 9000000614829

    Pharmacokinetics Research Laboratory, Taiho Pharmaceutical Co., Ltd. (1995 from CiNii)

    Articles in CiNii:1

    • Pharmacokinetic Studies on Propiverine Hydrochloride - Metabolites in Urinary Bladder, Other Tissues and Urine of Rats - (1995)
  • KAWAGUCHI Yasuro ID: 9000000636643

    大鵬薬品・代謝分析研 (2001 from CiNii)

    Articles in CiNii:16

    • 門脈 - 体循環血濃度差法によるイヌ小腸及び肝の初回通過効果 (2001)
    • テガフールからの5-フルオロウラシル生成におけるヒト肝P450およびチミジンホスホリラーゼの関与 (2001)
    • TAS-102経口投与におけるヒトFTD代謝の予測 (2001)
  • KAWAGUCHI Yasuro ID: 9000000638236

    Pharmacokinetics Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd. (1997 from CiNii)

    Articles in CiNii:1

    • Disposition of Components of New Anti-cancer Drug S-1 (7): Metabolism of Components of S-1 after Administration to Tumor bearing Rats (1997)
  • KAWAGUCHI Yasuro ID: 9000001148320

    Pharmacokinetics Research Laboratory, Taiho Pharmaceutical Co., Ltd. (2001 from CiNii)

    Articles in CiNii:1

    • Improvement in precision of the liquid chromatographic-electrospray ionization tandem mass spectrometric analysis of 3'-C-ethynylcytidine in rat plasma (2001)
  • KAWAGUCHI Yasuro ID: 9000005215886

    Reserch Institute, Taiho Pharmaceutical Co., Ltd. (1990 from CiNii)

    Articles in CiNii:1

    • Prediction of the Pharmacokinetics of Cefodizime and Cefotetan in Humans from Pharmacokinetic Parameters in Animals (1990)
  • KAWAGUCHI Yasuro ID: 9000011280555

    Pharmacokinetics Research Lab, Taiho Pharmaceutical Co., Ltd. (2002 from CiNii)

    Articles in CiNii:1

    • Comparative Analysis of In Vitro and In Vivo Pharmacokinetic Parameters Related to Individual Variability of GTS-21 in Canine (2002)
  • KAWAGUCHI Yasuro ID: 9000020375722

    Taiho Pharmaceutical Co., Ltd. (1990 from CiNii)

    Articles in CiNii:1

    • Phase I study of propiverine hydrochloride. The 2nd Report. Repeated oral dosing study.:The 2nd Report: Repeated Oral Dosing Study (1990)
  • KAWAGUCHI Yasuro ID: 9000020399041

    Taiho Pharmaceutical Co., Ltd (1990 from CiNii)

    Articles in CiNii:1

    • Phase I study of propiverine hydrochloride. The 1st report. Single oral dosing study.:The 1st Report: Single Oral Dosing Study (1990)
  • KAWAGUCHI Yasuro ID: 9000021027010

    Articles in CiNii:1

    • Occurrence of autoantibody to protein disulfide isomerase in rats with xenobiotic-induced hepatitis. (1994)
  • KAWAGUCHI Yasuro ID: 9000021033147

    Articles in CiNii:1

    • Occurrence of autoantibody to protein disulfide isomerase in patients with hepatic disorder. (1994)
  • KAWAGUCHI Yasuro ID: 9000252830959

    Pharmacokinetics Research Laboratory, Taiho Pharmaceutical Co., Ltd. (1995 from CiNii)

    Articles in CiNii:1

    • Pharmacokinetic Studies on Propiverine Hydrochloride. Metabolites in Urinary Bladder, Other Tissues and Urine of Rats.:Metabolites in Urinary Bladder, Other Tissues and Urine of Rats (1995)
  • KAWAGUCHI Yasuro ID: 9000252831235

    Tokushima Research Center, Taiho Pharmaceutical Co., Ltd (1997 from CiNii)

    Articles in CiNii:1

    • INACTIVATION MECHANISM OF HUMAN DIHYDROPYRIMIDINE DEHY DROGENASE BY 5-(2'-BROMOVINYL)URACIL, A METABOLITE OF THE ANTIVIRAL, SORIVUDINE (1997)
  • KAWAGUCHI Yasuro ID: 9000253209694

    Articles in CiNii:1

    • Prediction of the pharmacokinetics of cefodizime and cefotetan in humans from pharmacokinetic parameters in animals. (1990)
  • 1 / 3
Page Top